-
function of kidneys
- form urine - glomerular filtration, reabsorption, excretion
- erythropoietin - increase RBC to increase O2 carrying capacity (in response to tissue hypoxia)
- regulate BP - RAA - renin secreted by afferent arterioles in response to decreased BP
- electrolyte balance
- H2O balance - ADH
- pH balance - H+/HCO3- secretion/reabsorption if too acidi/alkaline
- activate vitamin D - stimulated by PTH in response to low blood calcium > calciferol (absorbs Ca/PO4 from small intestine)
-
glomerular filtration
- BP forces plasma, small proteins out of glomeruli into Bowman's capsule > renal filtrate
- GFR: amount of fluid filtered/filtrate formed per minute - 100-125mL/min
- increased BP in glomeruli (60 mmHg)
-
tubular reabsorption
recovery and return of useful materials from filtrate to circulation via peritubular capillaries
-
tubular secretion
- waste products actively secreted into filtrate
- ammonia, creatinine, medications
- H+ secreted/reabsorbed to maintain blood pH
- excess potassium secreted
-
elimination
ureters > bladder > urethra
-
urine
- 1-2L per 24 hours
- straw or amber colored
- clear vs cloudy
- ***specific gravity: 1.010-1.025***
- --<1.010: DI, overhydration, renal disease, potassium deficit (dilute)
- -->1.025: dehydration, fever, DM, vomiting, DHR (concentrated)
- pH: 4.6-8.0 - influenced by diet, meds (chemo is acidic > bladder hemorrhage > CBI to neutralize)
- 95% H2O, 5% nitrogenous waste (urea, creatinine, uric acid)
-
urinary system - aging
- decreased nephrons
- decreased GFR r/t decreased renal blood flow s/t arteriosclerosis
- decreased bladder size
- decreased detrusor muscle tone > increased frequency, PVR (s/b < 150, >150/250 = straight cath)
- increased UTIs
- decreased ability to concentrate urine
- increased r/f dehydration r/t decreased ability to compensate for salt intake
- decreased potassium excretion r/t decreased aldosterone levels
- fluid/electrolyte imbalances
- decreased drug clearance
-
kidney disorders
- congenital malformation
- polycystic kidney disease
- glomerular disorders (nephrotic syndrome)
- renal failure
-
polycystic kidney disease
- formation of fluid filled cysts, massive kidney enlargement
- hereditary
- two forms: autosomal dominant and autosomal recessive
- autosomal dominant - adults
- autosomal recessive - children
-
PKD patho
- renal cysts affect nephron
- fill, enlarge, multiply
- affect medulla and cortex
- cause fibrosis and scarring
-
PKD manifestations
- slow progression
- flank pain
- kidney concentration problems:
- --hematuria - microscopic or gross
- --proteinuria
- --polyuria
- --nocturia
- UTIs, renal calculi - cysts block normal drainage
- HTN - RAA
- enlarged, palpable kidneys
- renal insufficiency > CKD > ESRD
-
PKD dx
- renal ultrasound
- CT scan
- genetic testing
-
PKD tx
- supportive management
- avoid nephrotoxins - mycins, oral antidiabetics
- manage/avoid HTN
- avoid UTIs, lithiasis - fluid intake 2000 - 2500 mL
- hemodialysis > renal transplant
-
PKD nursing dx
- excess fluid volume r/t impaired renal function
- grieving r/t loss of kidney function
- readiness for enhanced knowledge
- risk for ineffective coping
-
glomerular disorders
- affect structure and function of glomerulus
- disrupts glomerular filtration
- capillary membrane more permeable to plasma proteins, blood cells > hematuria, proteinuria, edema
- decreased plasma proteins > increased filtrate > RAA stimulation > vasoconstriction, decreased GFR
- decreased GFR > HTN, azotemia (increased waste products [urea] in blood), oliguria (< 400mL for 24 hours)
-
glomerular manifestations
- hematuria r/t permeable membranes
- proteinuria r/t permeable membranes
- Na, H2O retention r/t increased aldosterone s/t RAA
- cola colored urine
- ***periorbital edema, dependent edema***
- HTN
- fatigue
- anorexia
- N&V
-
acute proliferative glomerulonephritis
- inflammation of glomerular capillary membrane
- caused by beta hemolytic strep infection
- circulating immune complexes become trapped in glomerular membrane
- tx: antibiotics, bed rest
-
Goodpasture's syndrome
- rare autoimmune disorder
- formation of antibodies to glomerular basement membrane
- tx: immunosuppression, plasmapheresis (remove antibody/antigen complex)
-
nephrotic syndrome
- group of clinical findings
- s/t malignancy, HTN, infection
- --proteinuria
- --hypoalbuminemia r/t protein loss in urine
- --hyperlipidemia r/t liver compensation for decreased proteins
- --edema
- risk for clotting, DVT, PE (decreased clotting factors)
- tx: ACE inhibitors, low sodium diet (1 to 2 g daily), moderate, complete proteins
-
chronic glomerulonephritis
- diabetic neuropathy - 40% of DM patients, leading cause of CKD
- lupus nephritis
-
glomerular disorder dx
- identify underlying disease process, preserve kidney function
- throat/skin culture, ASO titer - strep
- ESR - autoimmune
- KUB - kidney, ureter, bladder xray - enlarged kidneys (acute), small kidneys (late chronic)
- kidney scan - perfusion
- **biopsy - most reliable to determine type, prognosis, tx
-
glomerular disorder labs
- BUN - increased r/t azotemia
- serum creatinine - increased r/t decreased renal function (> 4 = serious)
- creatinine clearance - amt cleared in one minute - decreased
- serum albumin - decreased r/t proteinuria
- serum electrolytes - hyper except calcium
- RBC - decreased r/t decreased erythropoietin levels
- urine creatinine - decreased
- urine protein - increased
- urine RBC - increased
- GFR - decreased (normal > 60)
- "elevated potassium, phosphorus, decreased protein, pee pee"
-
glomerular disorder meds
- antibiotics if infectious
- immunosuppressive therapy if autoimmune
- oral glucocorticoids if autoimmune
- ACE inhibitors - renal protective, decrease BP
- antihypertensives - limit kidney damage
-
glomerular disorder nursing
- goal: maintain renal function, prevent complications, promote healing
- fluid volume excess - restrict fluids
- fatigue
- ineffective protection
- ineffective role performance
- pain
- ineffective breathing patterns
- anticipatory grieving
-
chronic kidney disease
- presence of kidney damage for 3+ months (GFR < 20)
- diffuse bilateral kidney disease with progressive destruction and scarring of whole nephron
- caused by
- --diabetes
- --HTN
- --pre-existing glomerular nephritis
-
CKD patho
- depends on underlying disorder
- gradual loss of entire nephron unit
- hypertrophy of remaining nephrons > increased glomerular capillary flow and pressure
- more solute particles filtered to compensate for lost renal mass
- increased demand cause scarring on remaining nephrons
- decreased renal reserve > renal insufficiency > renal failure > ESRD
-
decreased renal reserve
- GFR 50% of normal
- normal BUN
- slightly elevated creat
- asymptomatic
-
renal insufficiency
- GFR 20-50%
- mild azotemia
- increased BUN
-
renal failure
- GFR < 20%
- sharp increase in BUN/creat
-
ESRD
- GFR < 5%
- renal replacement therapy
-
uremia
- "urine in the blood" - build up of waste - severe azotemia
- nausea, apathy, weakness, fatigue, confusion
-
fluid/electrolyte imbalances
- impaired ability to regulate fluids, electrolytes, acid/base
- early stage: Na/H2O not conserved > dehydration, polyuria, nocturia, dilute urine
- late state: Na/H2O retained > FVE
- hyperkalemia - muscle weakness, paresthesia, EKG changes (when GFR < 5)
- hyperphosphatemia - excretion impaired
- hypermagnesemia - avoid antacids
- hypocalcemia - reduced calcium absorption r/t impaired vitamin D activation
- H+ excretion, bicarb production impaired - metabolic acidosis - Kussmaul respirations
-
cardiovascular effects
- accelerated atherosclerosis
- HTN r/t FVE, increase RAA, vascular resistance
- HF r/t FVE
- decreased contractility r/t acidosis
- hyperlipidemia
-
hematologic effects
- anemia r/t decreased erythropoietin, decreased life span s/t toxins in blood
- impaired platelet function
-
immune effects
- increased r/f infection - impaired inflammation and immune response r/t toxins
- suppressed fever
-
GI effects
- anorexia
- N&V
- hiccups
- uremic fetor - urine breath
-
neuro effects
- central and peripheral changes r/t uremia
- AMS, fatigue, insomnia
- restless legs, paresthesias r/t hypocalcemia
-
musculoskeletal effects
- hyperphosphatemia, hypocalcemia stimulate PTH > renal osteodystrophy (renal rickets) - softened bones, decreased bone mass
- bone tenderness, pain, muscle weakness
- Trousseau's, Chvostek's
-
endocrine/metabolic effects
- glucose intolerance
- high triglycerides
-
dermatologic effects
- uremic frost - crystals on skin from urea
- pallor r/t anemia
- yellow hue r/t retained metabolites
-
CKD dx
- urinalysis - specific gravity (low d/t impaired tubular secretion, reabsorption, concentration)
- urine culture - UTIs
- BUN - 20-50 = mild azotemia, 100+ = severe azotemia, 200+ = uremic sx
- serum creatinine > 4 = serious renal impairment
- eGFR - stage disease
- Na - normal to low d/t H2O retention
- K - elevated
- Phos - elevated
- Ca - decreased
- CBC - amemia, low platelets
- renal US - kidney size decreaed as nephrons destroyed
- kidney biopsy - determine underlying disease
-
CKD meds
- avoid nephrotoxic meds
- increased half-life
- avoid oral antidiabetics, NSAIDs
- ACE/ARBs - slow progression of CKD, HTN
- diuretics - reduce FV, edema, HTN, waste K
- Na bicarb/Ca bicarb - correct acidosis
- Phos-Lo - binds to phosporus to lower phosphate, normalize Ca
- High K levels - bicarb + insulin + glucose (move K back into cells)
- Kayexalate - excrete K
- folic acid/iron/vitamin D
-
CKD diet
- reduced protein - 0.6gm/kg/day
- increased carbs - 35cal/kg/day
- decreased Na and H2O as disease progresses
- decreased K - salt substitutes
- decreased phos - eggs, dairy, meat
-
CKD nursing dx
- goals: prevent further damage, minimize toxic waste, maintain nutritional status
- ineffective renal perfusion r/t nephron destruction
- imbalanced nutrition - less r/t anorexia, N&V
- risk for infection r/t altered immunity
- disturbed body image
|
|